Independently of food intake, previous preclinical and clinical studies have suggested that GDF15 may contribute to muscle atrophy in cancer cachexia by interacting with the muscle-specific E3 ubiquitin ligases MuRF1 and Atrogin1 [57]. Here, FBXO32 is linked to cancer.